Latest News

IDWeek: Generic lenacapavir could cost as little as $25 per person annually
IDWeek: Generic lenacapavir could cost as little as $25 per person annually

October 20th 2025

* Generic lenacapavir could be produced for $25 per person per year at scale, according to an analysis presented at IDWeek 2025 in Atlanta.

Maternal and Infant RSV Immunization Safe, Boosts Antibody Levels Regardless of Sequence | Image credit: © Peter Hansen  - © Peter Hansen - stock.adobe.com.
Maternal and infant RSV immunization safe, boosts antibody levels regardless of sequence

October 20th 2025

IDWeek 2025 to spotlight innovation, AI, and global collaboration in infectious diseases | Image Credit: © borisblik - stock.adobe.com.
IDWeek 2025 to spotlight innovation, AI, and global collaboration in infectious diseases

October 15th 2025

IDSA recommends use of scoring systems to guide testing for Group A Streptococcal pharyngitis | Image Credit: © kerkezz  - © kerkezz - stock.adobe.com.
IDSA recommends use of scoring systems to guide testing for group A streptococcal pharyngitis

October 15th 2025

Understanding the risks and benefits of current immunization practices | Image credit: borislav15 - stock.adobe.com
Understanding the risks and benefits of current immunization practices

October 6th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.